Kyoto University · Faculty of Pharmaceutical Sciences / Graduate School of Pharmaceutical Sciences

Research keywordsradiotheranostics・fibroblast activation protein・radiolabeled antibodies・microfluidic radiolabeling・carbonic anhydrase IX・radioimmunoconjugates・chelating agents・tumor retention

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Influence of the Binding Valency of Anti-HER2 Biparatopic Antibodies on Biodistribution in an SK-OV-3 Tumor Xenograft ModelMolecular Pharmaceutics,
• Effect of Structural Alteration in Albumin Binder Moiety on Tumor Accumulation of Somatostatin Receptor 2-Targeted RadioligandsACS Pharmacology & Translational Science,
• Improvement of tumor-to-blood ratio of radioimmunoconjugates by poly(ethyleneimine)-containing chelating agentAnnals of Nuclear Medicine,
• Radiotheranostics Using a Novel 225 Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane Antigen.Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane Antigen.

• Official profile